Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3527220 A
Publication typeGrant
Publication dateSep 8, 1970
Filing dateJun 28, 1968
Priority dateJun 28, 1968
Publication numberUS 3527220 A, US 3527220A, US-A-3527220, US3527220 A, US3527220A
InventorsSummers George Donald
Original AssigneeFairchild Hiller Corp
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Implantable drug administrator
US 3527220 A
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent Inventor George Donald Summers Stony Brook, New York Appl. No. 741,117

Filed June 28, 1968 Patented Sept. 8, 1970 Assignee Fairchlld Hiller Corporation Farmingdale, 12.1., New York a corporation of Maryland IMPLANTABLE DRUG ADMINISTRATOR 15 Claims, 5 Drawing Figs.

U.S. Cl 128/260, 3/1, 128/15, 128/273 Int. Cl. A61m 7/00 Field of Search 128/260,

[561 References Cited UNITED STATES PATENTS 2,625,158 1/1953 Lee et a1. 128/260 3,313,289 4/1967 Kapra1.... 3/1 3,443,561 5/1969 Reed 128/260 Primary Examiner-Adele M. Eager Attorney-Michael W. York ABSTRACT: An implantable drug administrator comprises a bladder having a self-sealing port through which it can be filled with a drug, a pump for selectively pumping the drug 7 from the bladder into any desired area of the body, and an indicator for indicating when the desired amount of the drug has been injected.

Patented Sept. 8, 1970 v 3,527,220

INVENTOR GEORGE DONALD SUMMERS ATTORNEYS IMPLANTABLE DRUG ADMINISTRATOR This invention relates to a device which can be implanted within an animal body for administering drugs or the like.

It has been proposed to implant a reservoir containing a drug or other medical preparation within a body cavity for purposes of administering the drug. to an animal. In such arrangements, the drug is generally permitted to escape into the body through perforations in the container or by diffusion through the container itself.

The prior art devices for this purpose have only attained limited utility principally because of their lack of reliability due, at least in part, to clogging of the container, and the obvious inconvenience of replacing an implantable container every time its drug supply is exhausted. Further drawbacks are the inability to situate the container in any desired area of the body while releasing the drug in a distant area ofthe body, and the lack of a practical monitoring device for assuring the proper operation of the system.

The present invention provides an improved implantable drug administration system which avoids the foregoing drawbacks and therefore is more reliable, easier to use, and of wider utility than known devices of this type.

Briefly, according to the invention, a drug is pumped from an implanted bladder by means of an implanted pump which is powered by an extra-corporeal magnetic field. The bladder includes a self-sealing port through which it can be refilled whenever desired. An implanted light source indicates the rate at which the drug is being pumped and thus can also be used to indicate the total dosage administered.

In the drawings:

FIG. 1 is a diagrammatic view showing how the invention typically would be implanted within the body ofa human;

FIG. 2 is a perspective view of the invention prior to being implanted;

FIG. 3 is a circuit diagram of the indicator circuit used in the preferred embodiment of the invention;

FIG. 4 is a detailed cross-sectional view of the inlet tube of the invention illustrated in FIG. 2; and

FIG. 5 is a detailed broken sectional view of the switch and the pump ofthe invention illustrated in FIG. 2.

In the specification and claims, the term "drug" is used in the broadest sense and includes all therapeutic and diagnostic agents such as hormones, vitamins, antibiotics, anticoagulants, cancericidal and spermicidal agents, vasoactive agents, and all other substances used to control, treat, or diagnose, or otherwise affect, physical or mental conditions (normal and abnormal) existing in and/or on an animal body.

Referring to FIGS. 1 and 2, the invention is shown as comprising a bladder and a pump 12 having an inlet line 14 connected to the lowermost point of bladder 10. The bladder 10 and pump 12 may be sutured in place within the abdominal cavity 16 of an individual, with a pump outlet line 18 leading into that portion of the body where it is desired to administer the drug.

Bladder 10 includes a port 20 which is self sealing and readily accessible from outside the individuals body although the port may be underneath the skin. A miniature light source 22 is sewn to bladder 10 within abdominal cavity 16, and, when energized, can be observed through the individuals skin. As explained below, light source 22 provides an indication of the dosage or amount of the drug within bladder 10 administered by the pump 12.

In the preferred embodiment of the invention, pump 12 is of the type disclosed in the May/June 1967 issue of The Journal of the Association for the Advancement of Medical Instrumentation, in an article entitled A New Miniature Pump for the Treatment of Hydrocephalus" by Summers and Mathews. As explained in that article, pump 12 includes a rotor assembly which is coupled through a gear train to a rotatable magnetic disc. The rotor contains three peripheral rollers which cyclically compress a length of tubing between the pump inlet 14 and outlet l8 with a peristatic action, thereby forcing fluid from inlet 14 to outlet 18. Since this construction is known, it is not illustrated and described here in detail.

The pump is driven by a rotatable magnet 24 located outside the body and rotated by a motor 26 suitably coupled thereto. The rotation of magnet 24 rotates the pump magnet by the pull of its magnetic field thus pumping the drug from bladder 10 through pump inlet tube 14 and outlet tube 18. This particular pump is highly desirable since it can be powered without penetrating the skin (exclusive of implantation), the advantages of which are self-evident. The specific pump per se, however, forms no part of this invention. The manner in which the invention is employed is obvious from the preceding explanation. After the bladder 10 and pump 12 have been implanted, the drug to be administered is injected into the bladder by means of a hypodermic needle and syringe or the like inserted through the seal-sealing plug 20. Thereafter, whenever it is desired to administer the drug, the motor 26 is energized to rotate magnet 24 thus driving pump 12 as explained above. The operation of the pump will cause the drug within bladder 10 to be administered through the distal end of outlet tube 18 wherever it is positioned.

The light source 22 may be energized a predetermined number of times during each revolution of the pump rotor to indicate that the pump is operating and to provide a measure of the dosage administered.

FIG. 2 shows certain specific details of the bladder 10, pump 12 and the energizing means for lamp 22. The pump is retained within a sealed stainless steel (or plastic) casing 30 which includes a flange 32 having apertures 34 by means of which the pump may be sewn into the body. A coil 36 is wrapped around a diameter of casing 30, with the coil leads 37 and 38 coupled, respectively to a miniature switch 40 within casing 30 and to the-lamp 22. Switch 40 (shown diagrammatically in FIG. 3) is a single-pole, single-throw (normally open) switch which can be closed in any suitable fashion each time a roller of the pump rotor traverses the pump tubing between inlet 14 and outlet 18. The operation of a preferred embodiment of switch 40 is explained below with reference to FIG. 5.

When the magnet 24 is rotated by motor 26, the resultant rotating magnetic field intersects coil 36 inducing a current in the coil. Accordingly, each time the contacts of switch 40 are closed, an energizing current is coupled to the light source 22. Thus, the energization of the light, which can be seen through the skin, indicates that the pump is operating properly. Since the volume amount of the drug displaced between successive rollers by rotation of the pump rotor is known, the flashes of light source 22 can be counted to measure the total administered dosage of the drug.

The bladder 10 includes an inner layer 50 coated with an outer layer 52 which is compatible with animal tissue. Various silicone rubber compositions are suitable for use as layer 52, representative examples being given in US Pat. No. 3,279,996 of Long. Since diffusion may occur through a silicone rubber layer, the inner layer 50 must be impervious to and not degraded by the drug used. Standard latex rubber is suitable for many purposes as the material of inner layer 50. The use of the silicone rubber layer provides a degree of selfsealing in the event the bladder is accidentally punctured during filling.

The self-sealing port 20 comprises a ring 54 made of a tissue compatible material such as a polycarbonate resin or stainless steel filled with a silicone rubber material 56 to a depth of about .25 inches. If necessary, an inner layer (not shown) of a material impervious to the drug may be used. The raised ring 54 enables the doctor to locate the port 20 through the skin. Where ring 54 is made of magnetically permeable material it can be located by a common stud finder or the like.

A stiff plastic or metal striker plate 58 is bonded to the interior layer 50 opposite port 20 as protection against accidental puncture of the bladder during injection of the drug. To ensure injection of the drug into the bladder, the inner surface of the port may be made concave so that there will always be a space between the port and striker plate 58.

As noted previously, the invention is not limited to any specific drug, and the drugs may be administered directly into tissue, organs, muscle, or body fluid (including blood). The

particular function in this respect will determine the size and construction of the needle or other termination of the outlet tube 18. As a specific example tube 18 may terminate in a rounded end 62 having side slots 64 through which the drug is dispensed. This construction will tend to prevent body fluid from entering tube 18 without interfering with the exit of the drug. A woven tube 66 (for example, of Dacron) may be bonded to the exterior surface of tube 18. Animal tissue will grow into tube 66 to help anchor the tube in the desired area of the body and to seal the penetration site against flow of body fluids.

The light source may comprise a diode made of gallium arsenide phosphide, requiring a forward bias of about 1.5 to 2.0 volts. It is less than a tenth of an inch in diameter and has an overall length of about an eighth of an inch, including the lens cap. It is rated at 50 foot-Lamberts brightness at a forward bias of 1.65 volts and forward current of 50 milliamperes. At that voltage it has a continuous forward current rating of 100 milliamperes.

In order to achieve maximum optical transmission through the skin, it is desirable to choose a wavelength in the zone of greatest skin transparency. However, this wavelength would be unsuitable as maximum transparency lies in the near-infrared region and is not visible to the human eye. On the other hand, the region of maximum sensitivity of the light-adapted human eye, about 570 millimicrons, is poorly transmitted through the skin. The wavelength of the selected lightemitting diode, in the 600-to-700 millimicron region, provides a compromise. The skin is reasonably transparent at this wavelength and the eye can easily detect the rich red color.

Some data on the depth of penetration of optical frequencies into the human have been reported. Penetration depth varies with skin pigmentation and is in the range of about two millimeters maximum. Data for transmission outward is not available, but in experiments the diode-emitted light was easily visible in a darkened room through chicken skin and tissue for depths of more than 8 millimeters. I

The energizing circuit for light source 22 is shown in FIG. 3. It is a simple series circuit and also includes a protective diode 70 which prevents the application of excessive back voltages to the light source 22.

In place of the coil 36, the power to operate lamp 22 may be provided by a battery or photo-voltaic cells. Also the coil 36 may be made responsive to an inductive or RF electromagnetic field.

In the preferred embodiment of the invention, the electrical leads are covered with an insulating material 72 (FIG. 4) such as Teflon and the solder joints coated with an epoxy (not shown). The wires are then bonded to the inlet tube 14 and the entire construction coated with a suitable silicone rubber composition 74.

A preferred construction for switch 40 is shown in FIG. 5. The pump includes a steel ring 80 within the pump casing 30. The pump rollers (one of which is shown at 82) compress the tubing 84 between inlet and outlet tubes 14 and 18 against ring 80. Switch 40 thus comprises the ring 80, a pressure sensitive paint 86, and a terminal 88 which is insulated from ring 80. The switch leads 37 and 37 are mechanically coupled through casing 30 (and suitably sealed) into electrical contact with ring 80 and terminal 88, respectively.

Paint 86 is ofa type which undergoes an increase in conductivity upon application of pressure thereto. (A suitable paint of this type is manufactured by Clark Electronics Laboratories of Palm Springs, California and sold under the trademark Micro-Ducer (type 9A).) Thus, each time a roller 82 passes over the terminal 88, the resultant increase in pressure closes" switch 40 to energize the light source 22.

Obviously, other switch constructions may be employed with the invention. A magnetically actuated mechanical switch would be of particular utility since it would enable a simple means for testing whether the signalling system was in proper working order by applying an external magnetic field to latch the switch in its closed condition. If, because of the magnetic fields required to operate pump 12, such a switch could not be employed in place of switch 40, a normally open switch of this type could be located at the bladder 10 and placed electrically in parallel with the contacts of switch 40. Such a switch is shown in dotted lines at in FIG. 3.

The visual signalling system of the invention would have utility in other applications apart from the specific case herein illustrated. For example, it could be used to test the continuity of circuits where breakage or interruption of leads is a problem (as with cardiac pacemakers).

Use of the invention is specifically contemplated in the treatment of diabetics or for chemotherapy of a carcinomatic condition. It could be used for the daily administration of a contraceptive, in the treatment of Hansens disease and in the administration of some hormones..The invention, however, is not in any respect limited as to its utility in special situations.

It is intended that the various parts of the invention will be sealed and coated with a tissue compatible material (such as silicone rubber) to whatever extent is required. Since silicone rubber is not a sealant, it may be necessary or desirable to coat the parts with a sealant (e.g. an epoxy) prior to applying the silicone rubber coating.

The invention can be used in many different ways to inject varying amounts of a drug ranging, for example, from microliters per day to milliliters per day. It can be used continuously and, conceivably, actuation of the pump may be made automatically responsive to a measurable body condition (e.g. oxygen partial pressure in the blood) or responsive to a programmed time schedule. The pump rotor can be made to rotate in both directions whereby a single pump can be used in conjunction with two bladders (and suitable valves) to selectively pump drugs from either bladder.


1. An implantable drug administrator for injecting a drug into an animal body comprising a bladder adapted to be implanted in the body having self-sealing means for permitting a drug to be injected into the interior of said bladder and a pump adapted to be implanted in the body for pumping the drug from said bladder, said pump having an inlet connected to said bladder and an outlet adapted to be positioned within said body.

2. An implantable drug administrator according to claim 1 wherein said self-sealing means comprises a port.

3. An implantable drug administrator according to claim 2 wherein said port includes a protruding ring.

4. An implantable drug administrator according to claim 2 including a striker plate bonded to said bladder in the area beneath said port.

5. An implantable drug administrator according to claim 2 wherein said port includes a magnetically permeable material.

6. An implantable drug administrator according to claim 1 including means connected to said pump for indicating the rate at which said pump is operating.

7. An implantable drug administrator according to claim 6 including means for testing the operation of said indicator means.

8. An implantable drug administrator according to claim 6 wherein said indicating means includes a coil for producing a current in response to a field exterior of said body.

9. An implantable drug administrator according to claim 8 wherein said pump is adapted to be operated by a magnetic field and said coil is wound around said pump to intersect said magnetic field.

- 10. An implantable drug administrator according to claim 8 wherein said indicating means includes a light source connected in circuit with said coil.

11. An implantable drug administrator according to claim 10 including a switch connected in circuit with said coil and said light source, said switch being adapted to be activated in response to the operation of said pump.

12. An implantable drug administrator according to claim 11 wherein said pump includes a rotor, and said switch is adapted to be activated by said rotor.

13. An implantable drug administrator according to claim 12 wherein said pump includes an outer casing and said switch is mounted within said casing.

14. An implantable drug administrator according to claim

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3604417 *Mar 31, 1970Sep 14, 1971American Cyanamid CoOsmotic fluid reservoir for osmotically activated long-term continuous injector device
US3640269 *Oct 24, 1969Feb 8, 1972Delgado Jose M RFluid-conducting instrument insertable in living organisms
US3692027 *Apr 23, 1971Sep 19, 1972Ellinwood Everett H JrImplanted medication dispensing device and method
US3730186 *Mar 5, 1971May 1, 1973Univ CalifAdjustable implantable artery-constricting device
US3731669 *Oct 16, 1970May 8, 1973Sander Nuclear CorpExternal implantation of energy to power internal devices
US3731681 *Jan 14, 1972May 8, 1973Univ MinnesotaImplantable indusion pump
US3750194 *Mar 16, 1971Aug 7, 1973Fairchild IndustriesApparatus and method for reversibly closing a natural or implanted body passage
US3757846 *Apr 12, 1971Sep 11, 1973Herman HMethod and apparatus for effecting electromagnetic displacement of fluids
US3765414 *Mar 10, 1972Oct 16, 1973Hydro Med Sciences IncDrug release system
US3783868 *May 6, 1971Jan 8, 1974Gulf Oil CorpPercutaneous implant
US3796217 *May 17, 1973Mar 12, 1974Hydr Med Sciences IncDrug release system
US3831583 *Feb 5, 1973Aug 27, 1974Univ CalifImplantable bulb for inflation of surgical implements
US3923060 *Apr 23, 1974Dec 2, 1975Jr Everett H EllinwoodApparatus and method for implanted self-powered medication dispensing having timing and evaluator means
US3971376 *Oct 2, 1974Jul 27, 1976Ceskoslovenska Akademie VedMethod and apparatus for introducing fluids into the body
US3996933 *Oct 4, 1975Dec 14, 1976Morton GutnickIntrauterine contraceptive devices and processes
US4013074 *Apr 6, 1976Mar 22, 1977Siposs George GImplantable medication-dispensing device
US4041954 *May 7, 1975Aug 16, 1977Kabushiki Kaisha Daini SeikoshaSystem for detecting information in an artificial cardiac pacemaker
US4102998 *Jul 1, 1976Jul 25, 1978Morton GutnickIntrauterine device which releases medication
US4133302 *Apr 29, 1977Jan 9, 1979The Commonwealth Industrial Gases LimitedInfant incubator
US4146029 *May 31, 1977Mar 27, 1979Ellinwood Jr Everett HSelf-powered implanted programmable medication system and method
US4152098 *Jan 3, 1977May 1, 1979Clark Ivan PMicropump
US4221219 *Jul 31, 1978Sep 9, 1980Metal Bellows CorporationImplantable infusion apparatus and method
US4253201 *May 24, 1979Mar 3, 1981Ross David AProsthesis with self-sealing valve
US4265241 *Feb 28, 1979May 5, 1981Andros IncorporatedImplantable infusion device
US4445826 *Jan 22, 1982May 1, 1984Polaroid CorporationPeristaltic pump apparatus
US4604090 *Nov 22, 1983Aug 5, 1986Consolidated Controls CorporationCompact implantable medication infusion device
US4615691 *Dec 8, 1983Oct 7, 1986Salomon HakimSurgically-implantable stepping motor
US4677982 *Mar 29, 1984Jul 7, 1987New York UniversityInfrared transcutaneous communicator and method of using same
US4687468 *Jul 25, 1986Aug 18, 1987Cook, IncorporatedImplantable insulin administration device
US4692147 *Jul 19, 1985Sep 8, 1987Medtronic, Inc.Drug administration device
US4710177 *May 15, 1986Dec 1, 1987Smith Robert RSubcutaneous ventricular injection apparatus and method
US4747832 *May 16, 1986May 31, 1988Jacques BuffetDevice for the injection of fluid, suitable for implantation
US4772257 *Oct 7, 1986Sep 20, 1988Salomon HakimAdjusting the working pressure of a surgically-implanted valve
US4816016 *Mar 18, 1988Mar 28, 1989Pudenz-Schulte Medical Research Corp.Subcutaneous infusion reservoir and pump system
US4820273 *Mar 1, 1988Apr 11, 1989Eaton CorporationImplantable medication infusion device and bolus generator therefor
US4840190 *Apr 14, 1988Jun 20, 1989Dow Corning WrightLozenge-shaped low profile injection reservoir
US4884013 *Jan 15, 1988Nov 28, 1989Sherwood Medical CompanyMotor unit for a fluid pump and method of operation
US5061243 *Feb 8, 1989Oct 29, 1991Baxter International Inc.System and apparatus for the patient-controlled delivery of a beneficial agent, and set therefor
US5085644 *May 20, 1991Feb 4, 1992Pudenz-Schulte Medical Research CorporationSterilizable medication infusion device with dose recharge restriction
US5152753 *Apr 2, 1990Oct 6, 1992Pudenz-Schulte Medical Research CorporationMedication infusion device with dose recharge restriction
US5762599 *May 2, 1994Jun 9, 1998Influence Medical Technologies, Ltd.Magnetically-coupled implantable medical devices
US6458118 *Feb 23, 2000Oct 1, 2002Medtronic, Inc.Drug delivery through microencapsulation
US6485462Aug 24, 2000Nov 26, 2002Science IncorporatedFluid delivery device with heat activated energy source
US6582418Jun 1, 2000Jun 24, 2003Medtronic, Inc.Drug pump with reinforcing grooves
US6592571May 24, 2000Jul 15, 2003Medtronic, Inc.Drug pump with suture loops flush to outer surface
US6719739Aug 27, 2001Apr 13, 2004Medtronic, Inc.System and method for attaching upper and lower outer cases in an implantable drug pump
US6986751Oct 31, 2003Jan 17, 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US6991615Aug 2, 2004Jan 31, 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US7011643Aug 5, 2003Mar 14, 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US7341577Apr 30, 2003Mar 11, 2008Renishaw PlcImplantable drug delivery pump
US7361168Aug 4, 2004Apr 22, 2008Acclarent, Inc.Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7410480Sep 23, 2005Aug 12, 2008Acclarent, Inc.Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7419497Oct 4, 2006Sep 2, 2008Acclarent, Inc.Pushing a sinus needle having a sheath through the ethmoid bulla to create an opening into ethmoid air cell; removing sinus needle from sheath; inserting an implantable device; removing the sheath;delivering a therapeutic substance into the reservoir; allowing the reservoir to remain implanted
US7547323Aug 29, 2006Jun 16, 2009Sinexus, Inc.Stent for irrigation and delivery of medication
US7720521Apr 26, 2005May 18, 2010Acclarent, Inc.Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses
US7785315Dec 12, 2007Aug 31, 2010Acclarent, Inc.Methods for irrigation of ethmoid air cells and treatment of ethmoid disease
US7862502Jun 8, 2007Jan 4, 2011Ellipse Technologies, Inc.Method and apparatus for adjusting a gastrointestinal restriction device
US7967806Mar 25, 2004Jun 28, 2011Medtronic, Inc.Method of delivering a fluid medication to a patient in flex mode
US7967812Oct 22, 2002Jun 28, 2011Medtronic, Inc.Drug infusion system programmable in flex mode
US7981025Oct 28, 2008Jul 19, 2011Ellipse Technologies, Inc.Adjustable implant and method of use
US8080000Oct 30, 2007Dec 20, 2011Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US8088101Oct 26, 2007Jan 3, 2012Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US8090433Oct 30, 2007Jan 3, 2012Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US8100933May 8, 2008Jan 24, 2012Acclarent, Inc.Method for treating obstructed paranasal frontal sinuses
US8114062Oct 1, 2009Feb 14, 2012Acclarent, Inc.Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8114113Oct 4, 2005Feb 14, 2012Acclarent, Inc.Multi-conduit balloon catheter
US8118757Apr 30, 2007Feb 21, 2012Acclarent, Inc.Methods and devices for ostium measurement
US8123722Oct 29, 2007Feb 28, 2012Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US8142422Mar 4, 2008Mar 27, 2012Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US8146400Jul 31, 2007Apr 3, 2012Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US8172828Oct 30, 2007May 8, 2012Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8182432Mar 10, 2008May 22, 2012Acclarent, Inc.Corewire design and construction for medical devices
US8190389May 17, 2006May 29, 2012Acclarent, Inc.Adapter for attaching electromagnetic image guidance components to a medical device
US8246533Jun 8, 2007Aug 21, 2012Ellipse Technologies, Inc.Implant system with resonant-driven actuator
US8277503May 7, 2009Oct 2, 2012Intersect Ent, Inc.Stent for irrigation and delivery of medication
US8277504May 7, 2009Oct 2, 2012Intersect Ent, Inc.Stent for irrigation and delivery of medication
US8317816Sep 30, 2002Nov 27, 2012Acclarent, Inc.Balloon catheters and methods for treating paranasal sinuses
US8388642Aug 29, 2008Mar 5, 2013Acclarent, Inc.Implantable devices and methods for treating sinusitis and other disorders
US8414473Sep 16, 2009Apr 9, 2013Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US8425457Dec 29, 2009Apr 23, 2013Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitus and other disorder of the ears, nose and/or throat
US8435290Mar 24, 2010May 7, 2013Acclarent, Inc.System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US8439687Dec 29, 2006May 14, 2013Acclarent, Inc.Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US8480655Jun 21, 2011Jul 9, 2013Medtronic, Inc.Drug infusion system programmable in flex mode
US8485199May 8, 2007Jul 16, 2013Acclarent, Inc.Methods and devices for protecting nasal turbinate during surgery
US8545255 *Apr 23, 2010Oct 1, 2013Centre Hospitalier Universitaire De RouenSubcutaneous device for electrical percutaneous connection
US8639353Apr 23, 2010Jan 28, 2014Centre Hospitalier Universitaire De RouenElectrical connection device implantable in the human body
US8702626Dec 29, 2006Apr 22, 2014Acclarent, Inc.Guidewires for performing image guided procedures
US8715159Jun 10, 2011May 6, 2014Ellipse Technologies, Inc.Adjustable implant and method of use
US8715169Oct 30, 2007May 6, 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US8721591Jan 23, 2012May 13, 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8740929Feb 6, 2002Jun 3, 2014Acclarent, Inc.Spacing device for releasing active substances in the paranasal sinus
US8747389Apr 24, 2007Jun 10, 2014Acclarent, Inc.Systems for treating disorders of the ear, nose and throat
US8764709Jun 30, 2010Jul 1, 2014Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US8764726Aug 18, 2009Jul 1, 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US8764729Dec 22, 2008Jul 1, 2014Acclarent, Inc.Frontal sinus spacer
US8764786Oct 9, 2012Jul 1, 2014Acclarent, Inc.Balloon catheters and methods for treating paranasal sinuses
US8777926Mar 15, 2013Jul 15, 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasel or paranasal structures
US8808163Oct 11, 2012Aug 19, 2014Ellipse Technologies, Inc.Adjustable implant and method of use
US20120045918 *Apr 23, 2010Feb 23, 2012Pierre-Yves LitzlerSubcutaneous device for electrical percutaneous connection
EP0140727A1 *Aug 14, 1984May 8, 1985Jacques BuffetImplantable fluid injection device
EP0392566A1 *Sep 24, 1985Oct 17, 1990Cook IncorporatedImplantable insulin administration device
EP1772162A1 *Oct 8, 2005Apr 11, 2007Boehringer Mannheim GmbhInfusion system for delivery of a liquid drug
EP2288406A2 *Jun 22, 2009Mar 2, 2011Yehoshua ShacharA magnetic breather pump and a method for treating a brain tumor using the same
WO1980001755A1 *Feb 25, 1980Sep 4, 1980Andros IncImplantable infusion device
WO2002017989A2Aug 29, 2001Mar 7, 2002Medtronic IncSystem and method for attaching upper and lower outer cases in an implantable drug pump
U.S. Classification604/153
International ClassificationA61M5/142, F04B43/12
Cooperative ClassificationA61M5/14276, A61M2205/3515, F04B43/1238
European ClassificationF04B43/12F, A61M5/142P10